Centiva Capital’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-50,000
Closed -$4K 1839
2022
Q3
$4K Hold
50,000
﹤0.01% 1417
2022
Q2
$5K Hold
50,000
﹤0.01% 1593
2022
Q1
$17K Hold
50,000
﹤0.01% 1501
2021
Q4
$26K Hold
50,000
﹤0.01% 1107
2021
Q3
$29K Hold
50,000
﹤0.01% 1170
2021
Q2
$36K Buy
+50,000
New +$28.3K ﹤0.01% 1299

Other funds holding EQHA.WS

Centiva Capital's EQHA.WS Position: Q4 2022 in Review

Centiva Capital sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 50,000 shares — an estimated $4K sold.

Centiva Capital first reported a position in EQHA.WS in Q2 2021 and held it in 6 quarters. The position peaked at $36K in Q2 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

  • Centiva Capital reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
  • Centiva Capital sold 50,000 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $4K.
  • Centiva Capital first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q2 2021 and held it in 6 quarters.
  • Centiva Capital's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $36K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Centiva Capital's 13F filing for Q4 2022, filed 14 Feb 2023.